Shell invests in Codexis enzymes development
Royal Dutch Shell recently announced it would make an equity investment in Codexis Inc., a developer of biocatalytic process technologies. In addition, Shell will take a seat on the Codexis board. The collaboration will cover five years in the research and development of super enzymes capable of outperforming naturally occurring molecules to biofuels production. Codexis has applied its enzyme-development technology in the pharmaceutical industry and has been working with Shell since November 2006 to tailor its technology to the biofuels industry.